Benign Prostatic Hyperplasia Treatment Market would record a value tantamount to US$ 12 Bn by 2027.
An exhaustive study published by Fact.MR finds that, transurethral resection of prostate (TURP) surgery is expected to contribute around 30% of market share by 2027, [read full press release…]